NuCana appoints GSK oncology head
December 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, biomed, nucana
Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors. Paoletti has been …
AZ and Lilly Alzheimer’s drug enters trials
December 1, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, AstraZeneca, LY3314814, lilly
AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …
£2 billion government plan to ‘save the NHS’
December 1, 2014Sales and Marketing Conservatives, NHS, Osborne, UK, balls, election, spending
George Osborne in his Autumn Statement on Wednesday will announce an extra £2 billion funding for the NHS in an attempt …
CRF Health expands leadership team
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing crf health, enbuska, john blakeley
Clinical trials e-solutions firm CRF Health has announced two new additions to the company’s executive leadership team. John Blakeley (pictured) …
George Freeman: UK pharma is vital for our landscape
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified
The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …
Boehringer’s lung cancer drug Vargatef sees EU approval
November 28, 2014Sales and Marketing Boehringer, EU, Europe, IPF, NSCLC, lung cancer, nintedanib, ofev, vargatef
Boehringer Ingelheim’s nintedanib has received its second nod in Europe this month with the European Commission approving it for the …
New Teva chairman announced
November 28, 2014Manufacturing and Production, Sales and Marketing Phillip Frost, Teva, Yitzhak Peterburg, barer, generics, israel
Teva Pharmaceutical Industries has confirmed that Professor Yitzhak Peterburg is to serve as its new chairman from January. Peterburg who …
Bone Therapeutics appoints Pfizer veteran
November 28, 2014Belgium-based biotech Bone Therapeutics has appointed Dr Guy Heynen as its new chief clinical and regulatory officer. Heynen is a …
CRUK and AZ collaborate on cancer screening
November 28, 2014Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, Cancer, Cancer Research UK, MRC
Cancer Research UK (CRUK) scientists are to be given access to drug discovery facilities at AstraZeneca’s Cambridge site as part …
GSK Ebola vaccine ‘promising’ in early trials
November 27, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines
The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …
Lundbeck’s alcohol pill given NICE approval
November 27, 2014Sales and Marketing Lundbeck, NHS, NICE, alcohol, selincro
NICE has finally approved the use of Selincro (nalmefene) in order to help people who are dependent on alcohol cut …
NHS to get world’s most expensive drug
November 27, 2014Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris
UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS). Soliris …
NHS needs £2 billion more in funding
November 26, 2014Medical Communications, Sales and Marketing Cameron, Hunt, Kings Fund, NHS, Osborne, king's fund, statement
Healthcare think tank the King’s Fund has called for an additional £2 billion to be injected into the NHS in …
UK lags behind in healthcare outcomes index
November 26, 2014Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes
Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …
Sharp Packaging Services hires MD
November 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mike O’Hara, Sharp Packaging Services
Sharp Packaging Services that is a part of UDG Healthcare has announced that Mike O’Hara has joined the firm as …
Mental and physical health should be treated equally
November 26, 2014Medical Communications, Research and Development, Sales and Marketing Campbell, Lundbeck, depression, kofi annan, wiinberg
The need for a new approach to depression that gives it equal importance to physical health was the focus of …
Cell Medica gets £50 million funding
November 26, 2014Research and Development, Sales and Marketing CMD-003, Cancer, Imperial Innovations, Invesco Perpetual, Woodford Investment Management, celk medica
Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …
Priority review for Novartis myeloma drug
November 26, 2014Sales and Marketing FDA, Farydak, Novartis, daratumumab, elotuzumab, myeloma, odac
Novartis’ multiple myeloma treatment Farydak has been given an extended review by the FDA after its future seemed in jeopardy …
Institute of Cancer Research names chief executive
November 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICR, Institute of Cancer Research, paul workman
Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …
BioMarin to buy Prosensa in $840 million deal
November 25, 2014Sales and Marketing BioMarin, Prosensa, drisapersen, dystrophy
Rare-disease drug firm BioMarin has finalised its purchase of muscular disease specialist Prosensa in a deal worth over $840 million. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
